cefprozil (Harmonic Pharma/Institut Curie)

N/A

Report date: 2025/06/11 10:30:30
NME

Base Information

Drug Namecefprozil (Harmonic Pharma/Institut Curie)
Drug Alias NameArmoncocefprozil
ClassificationSmall molecules
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsLung NeoplasmsTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarmonic Pharma
China Registration ClassN/A

Develop Information

Active CompaniesHarmonic PharmaInstitut Curie
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A